Half-value duration
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Half-value duration (HVD or HaVD), also known as T50%Cmax, is a pharmacokinetic parameter defined as the time for circulating concentrations to decline to 50% of the peak or maximal concentration (C max ). It was introduced by J. Meier and colleagues in 1974 for description of modified-release drug formulations. Related metrics include T75%Cmax and T25%Cmax, among others.
Half-value duration (HVD or HaVD), also known as T50%Cmax, is a pharmacokinetic parameter defined as the time for circulating concentrations to decline to 50% of the peak or maximal concentration (C max ). It was introduced by J. Meier and colleagues in 1974 for description of modified-release drug formulations. Related metrics include T75%Cmax and T25%Cmax, among others.
See also
Elimination (pharmacology) Biological half-life Residence time
Text derived from https://en.wikipedia.org/w/index.php?oldid=1342826506 under CC BY-SA 4.0; modifications have been made.